Search hospitals > Illinois > Niles

Illinois Cancer Specialists-Niles

Claim this profile
Niles, Illinois 60714
Global Leader in Cancer
Global Leader in Lung Cancer
Conducts research for Lymphoma
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
167 reported clinical trials
3 medical researchers
Photo of Illinois Cancer Specialists-Niles in NilesPhoto of Illinois Cancer Specialists-Niles in NilesPhoto of Illinois Cancer Specialists-Niles in Niles

Summary

Illinois Cancer Specialists-Niles is a medical facility located in Niles, Illinois. This center is recognized for care of Cancer, Lung Cancer, Lymphoma, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Illinois Cancer Specialists-Niles is involved with conducting 167 clinical trials across 184 conditions. There are 3 research doctors associated with this hospital, such as Leonard Klein, Urszula Sobol, MD, and Sonia Christian, MD.

Area of expertise

1Cancer
Global Leader
Illinois Cancer Specialists-Niles has run 35 trials for Cancer. Some of their research focus areas include:
Stage IV
Stage III
PR positive
2Lung Cancer
Global Leader
Illinois Cancer Specialists-Niles has run 29 trials for Lung Cancer. Some of their research focus areas include:
Stage IV
PD-L1 negative
Stage I

Top PIs

Clinical Trials running at Illinois Cancer Specialists-Niles

Follicular Lymphoma
Cancer
Multiple Myeloma
Lung Cancer
Non-Small Cell Lung Cancer
Tumors
Lymphoma
Small Cell Lung Cancer
Plasma Cell Myeloma
Plasma Cell Neoplasms
Image of trial facility.

Epcoritamab

for Lymphoma

B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Follicular Lymphoma is a slow-growing type of non-Hodgkin lymphoma. The purpose of this study is to assess the safety of epcoritamab in adult participants in relapsed or refractory (R/R) diffuse large b-cell lymphoma (DLBCL) or R/R follicular lymphoma (FL). Adverse events will be assessed. Epcoritamab is an investigational drug being developed for the treatment of R/R DLBCL and R/R FL. Study doctors will assess participants in a monotherapy treatment arm of epcoritamab. Participants will receive escalating doses of epcoritamab, until full dose is achieved. Approximately 184 adult participants with R/R DLBCL and R/R FL will be enrolled in the study in approximately 80 sites in the United States of America. Participants will receive escalating doses of subcutaneous epcoritamab, until full dose is achieved, in 28-day cycles. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at an approved institution (hospital or clinic). The effect of the treatment will be frequently checked by medical assessments, blood tests, questionnaires and side effects.
Recruiting1 award Phase 23 criteria
Image of trial facility.

Tazemetostat + Lenalidomide + Rituximab

for Follicular Lymphoma

This study is evaluating whether a combination of two drugs may help treat people with a certain type of leukemia.
Recruiting1 award Phase 34 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Illinois Cancer Specialists-Niles?
Illinois Cancer Specialists-Niles is a medical facility located in Niles, Illinois. This center is recognized for care of Cancer, Lung Cancer, Lymphoma, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Illinois Cancer Specialists-Niles is involved with conducting 167 clinical trials across 184 conditions. There are 3 research doctors associated with this hospital, such as Leonard Klein, Urszula Sobol, MD, and Sonia Christian, MD.